These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8335441)

  • 1. [Myelodysplastic syndrome and secondary leukemia].
    Wörmann B
    Internist (Berl); 1993 Jun; 34(6):518-25. PubMed ID: 8335441
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic variables in bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey of the working party on leukaemia.
    de Witte T; Hermans J; van Biezen A; Vernant J; Kolb H; Zwaan F; Vossen J; Lönnqvist B; Beelen D; Ferrant A
    Bone Marrow Transplant; 1991; 7 Suppl 2():40. PubMed ID: 1878713
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute myelogenous leukemia and myelodysplastic syndromes.
    Estey EH
    Semin Hematol; 1995 Apr; 32(2):132-51. PubMed ID: 7652581
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients.
    Sutton L; Leblond V; Le Maignan C; Jouet JP; Kuentz M; Gluckman E; Blaise D; Marit G; Attal M; Troussard X
    Bone Marrow Transplant; 1991; 7 Suppl 2():39. PubMed ID: 1878712
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marrow transplantation for patients with severe myelodysplasia.
    Appelbaum FR; Buckner CD
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():40. PubMed ID: 2627606
    [No Abstract]   [Full Text] [Related]  

  • 7. Bibliography. Current world literature. Leukemia.
    Curr Opin Oncol; 2001 Jan; 13(1):B1-14. PubMed ID: 11196243
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute leukemia].
    Smirnov AN
    Feldsher Akush; 1986 Oct; 51(10):17-23. PubMed ID: 3542590
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelodysplastic syndromes].
    Sizoo W; Hagenbeek A; Löwenberg B; van 't Veer MB; Sintnicolaas K
    Ned Tijdschr Geneeskd; 1987 Sep; 131(38):1658-61. PubMed ID: 3313069
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of a secondary myelodysplastic syndrome after allogenic bone marrow transplantation using Mylotarg.
    Hermida G; Manjón R; Rodríguez-Salazar I; Richard C
    Haematologica; 2002 Apr; 87(4):ECR14. PubMed ID: 11940496
    [No Abstract]   [Full Text] [Related]  

  • 11. [Primary myelodysplastic syndromes].
    Brohée D
    Rev Med Brux; 1988 Sep; 9(6):327-33. PubMed ID: 3051250
    [No Abstract]   [Full Text] [Related]  

  • 12. [The therapy of myelodysplastic syndromes].
    Aul C; Heyll A
    Dtsch Med Wochenschr; 1990 Nov; 115(48):1842-50. PubMed ID: 2245768
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis.
    Imrie KR; Dubé I; Prince HM; Girouard C; Crump M; Keating A
    Bone Marrow Transplant; 1998 Feb; 21(4):395-9. PubMed ID: 9509975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
    Cheson BD
    Semin Oncol; 1992 Feb; 19(1):85-94. PubMed ID: 1736371
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
    Gassmann W; Schmitz N; Löffler H; De Witte T
    Semin Hematol; 1996 Jul; 33(3):196-205. PubMed ID: 8819230
    [No Abstract]   [Full Text] [Related]  

  • 18. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ Myelodysplastic syndrome].
    Fenaux P
    Rev Prat; 2002 Dec; 52(20):2301-8. PubMed ID: 12621953
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelodysplastic syndrome in a child with a history of medulloblastoma.
    Akyüz C; Emir S; Güler N; Tüker A; Büyükpamukçu M
    Turk J Pediatr; 1998; 40(1):131-4. PubMed ID: 9673540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.